RecruitingACTRN12610000246088

SUSTAIN For PAIN

SUSTAIN For PAIN: Subcostal UltraSound guided Transversus Abdominis plane INfusions for Pain relief of Abdominal INcisions


Sponsor

Western Hospital

Enrollment

80 participants

Start Date

Feb 1, 2011

Study Type

Interventional

Conditions

Summary

To evaluate whether local anaesthetic running via a catheter in the abdominal wall improves analgesia following abdominal surgery


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This trial is testing whether a continuous local anesthetic delivered through a small tube (catheter) into the abdominal wall can help people recover from abdominal surgery with less pain. After operations that require a large incision down the middle of the belly, pain management is very important. Researchers want to find out if this extra pain-blocking method, combined with standard care, reduces pain better than standard care alone. You may be eligible if: - You are 18 years or older - You are scheduled for elective or semi-elective abdominal surgery requiring a midline incision - Your surgical plan includes standard pain-blocking injections and a patient-controlled morphine pump after surgery You may NOT be eligible if: - You are planned to receive an epidural or spinal block for pain relief - You have kidney problems (low creatinine clearance) or severe liver disease - You cannot communicate in English or cannot operate a patient-controlled pain pump - You regularly use large amounts of opioid pain medications (e.g., morphine, oxycodone, fentanyl patch, methadone, buprenorphine) - You have used illicit injected or inhaled drugs in the past 6 months - You have a history of chronic pain, uncontrolled epilepsy, or allergies to the study medications - You are taking certain medications including MAOIs, SSRIs, antipsychotics, or warfarin Talk to your doctor about whether this trial might be right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Ropivacaine Transversus Abdominis Plane infusion at a rate of 0.1ml/kg/hr bilaterally up to a maximum of 7ml/hr bilaterally via transversus abdominis plane catheter for 48 hours. The infusion rate wil

Ropivacaine Transversus Abdominis Plane infusion at a rate of 0.1ml/kg/hr bilaterally up to a maximum of 7ml/hr bilaterally via transversus abdominis plane catheter for 48 hours. The infusion rate will be rounded down to the nearest integer (e.g. a 68 kg patient will receive an infusion rate of 6 ml/hr bilaterally).


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000246088